What is Standard Chemical & Pharmaceutical Co Net Margin %?
Standard Chemical & Pharmaceutical CoTPE:1720 95 Net Margin % is 12.84% as of Dec. 2025, which is 2% above its 10-year median of 12.57. GuruFocus rates TPE:1720 with a GF Score™ of 95/100 and a GF Value™ of NT$70.93 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 957 Drug Manufacturers companies, Standard Chemical & Pharmaceutical Co ranks better than 74.19% on this metric.
TPE:1720'
s Net Margin % Range Over the Past 10 Years
Min: 9.26 Med: 12.57 Max: 15.35
Current: 13.21
TPE:1720's Net Margin % is ranked better than 74.19% of 957
companies
in the Drug Manufacturers industry
Industry Median: 5.58
vs TPE:1720: 13.21
Standard Chemical & Pharmaceutical Co (TPE:1720) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Standard Chemical & Pharmaceutical Co Net Margin % Related Terms
Standard Chemical & Pharmaceutical Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Standard Chemical & Pharmaceutical Co Net Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Standard Chemical & Pharmaceutical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Standard Chemical & Pharmaceutical Co Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Standard Chemical & Pharmaceutical Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Standard Chemical & Pharmaceutical Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Standard Chemical & Pharmaceutical Co (TPE:1720) has a Net Margin % of 12.84% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Standard Chemical & Pharmaceutical Co and its competitors. This is near median its historical median of 12.57. Over the past decade, Standard Chemical & Pharmaceutical Co's Net Margin % has ranged from 9.26 to 15.35. According to the industry distribution chart, Standard Chemical & Pharmaceutical Co ranks #247 out of 957 companies in the Drug Manufacturers industry, placing it in the top 25.8%.
Is Standard Chemical & Pharmaceutical Co's Net Margin % too high?
Standard Chemical & Pharmaceutical Co's current Net Margin % of 12.84% is near median its 10-year median of 12.57. Over the past 10 years, this metric has ranged from a low of 9.26 to a high of 15.35. The Drug Manufacturers industry median Net Margin % is 5.58. Standard Chemical & Pharmaceutical Co's value of 12.84% is 130.1% above this industry median. Based on the distribution chart, Standard Chemical & Pharmaceutical Co ranks #247 out of 957 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Standard Chemical & Pharmaceutical Co has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Standard Chemical & Pharmaceutical Co's Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Standard Chemical & Pharmaceutical Co ranks #247 out of 957 companies for Net Margin %. This puts Standard Chemical & Pharmaceutical Co in the upper half of its industry. The industry median Net Margin % is 5.58. Standard Chemical & Pharmaceutical Co's value of 12.84% is 130.1% above this benchmark. Historically, Standard Chemical & Pharmaceutical Co's own Net Margin % has ranged from 9.26 to 15.35 over the past decade. While the company's 10-year median is 12.57 vs. the industry median of 5.58, Standard Chemical & Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.58, based on 957 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Standard Chemical & Pharmaceutical Co's current Net Margin % of 12.84% is 130.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Standard Chemical & Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Standard Chemical & Pharmaceutical Co's current Net Margin % is 12.84%, which is near median its own 10-year median of 12.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Standard Chemical & Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Standard Chemical & Pharmaceutical Co (TPE:1720) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$70.93, compared to a current price of NT$63.90 — trading 9.9% below its estimated fair value. The current Net Margin % is 12.84%, which is near median its 10-year median of 12.57 and 130.1% above the Drug Manufacturers industry median of 5.58. Standard Chemical & Pharmaceutical Co's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Standard Chemical & Pharmaceutical Co (TPE:1720), the current Net Margin % is 12.84% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Standard Chemical & Pharmaceutical Co (TPE:1720) Overvalued in 2026?
Based on GuruFocus' analysis, Standard Chemical & Pharmaceutical Co stock appears to be undervalued.
The current stock price of NT$63.90 is trading 9.9% below its estimated GF Value™ of NT$70.93.
GuruFocus considers Standard Chemical & Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for TPE:1720:
Net Margin %: 12.84% (near median its 10-year median of 12.57)
GF Value™: NT$70.93 vs. price of NT$63.90 (9.9% below fair value)
Industry Position: 130.1% above the Drug Manufacturers median (#247 of 957)
No single metric tells the full story. See the TPE:1720 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Standard Chemical & Pharmaceutical Co Business Description
Standard Chemical & Pharmaceutical Co Ltd is engaged in the manufacturing and sales of Chinese and western medicine, cosmetics, beverage, normal instruments and medical instruments. Its segments include Medicine, Dietary supplement and Ingredients. The majority of the revenue is derived from the Medicine segment. Geographically it operates in Taiwan, Japan and Others with Taiwan generating the maximum revenue.
95GF Score
Get the complete analysis for TPE:1720
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1720 has been successfully added to your 
